EMGLIF MXR 25/1000MG TAB

Emglif MXR 25/1000mg Tablet is a combination medication containing vildagliptin and metformin, designed to help manage type 2 diabetes mellitus. Vildagliptin works by enhancing insulin secretion in response to elevated blood glucose levels, while metformin reduces hepatic glucose production and improves insulin sensitivity. This dual-action formulation provides comprehensive glycemic control for patients requiring combination therapy. Suitable for adults with inadequate glucose management on monotherapy.